Author Reflects on Inspiring Journey of Spiritual Growth, Shares Experiences Healing from Bipolar Disorder in Debut Memoir
July 13, 2020 08:00 ET | XlibrisUS
NAPLES, Fla., July 13, 2020 (GLOBE NEWSWIRE) -- Author Bárbaro Baez Alvarez has published his debut, inspirational self-help memoir that twines his journey of spiritual growth with his experiences...
OWP_Logo_Primary.png
OWP Pharmaceuticals Announces Pre-IND Acknowledgement and Patent Application for the First-Ever Liquid Oral Suspension Formulation of Quetiapine Fumarate for the Treatment of Schizophrenia and Bipolar Disorder
January 08, 2020 08:00 ET | OWP Pharmaceuticals
NAPERVILLE, Ill., Jan. 08, 2020 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc., a privately-held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and...
OWP_Logo_Primary.png
OWP Pharmaceuticals Announces a Second IND Approval and Patent Application: The First-Ever Liquid Oral Suspension Formulation of Lamotrigine for the Treatment of Epilepsy and Bipolar Disorder
December 03, 2019 08:00 ET | OWP Pharmaceuticals
NAPERVILLE, Ill., Dec. 03, 2019 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc., a privately-held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and...
RND logo.PNG
Neuroleptics Market To Reach USD 15.41 Billion By 2026 | Reports And Data
April 15, 2019 12:39 ET | Reports And Data
Increase in health awareness is expected to be a prime factor driving the market growth; the rising incidences of mental disorders are also expected to grow the market demand in the future. Market...